Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review

Susmitha Apuri, Kristin Carlin, Edward Bass, Phuong Thuy Nguyen, John Norman Greene
  • Susmitha Apuri
    Moffitt Cancer Center, University of South Florida College of Medicine, United States
  • Kristin Carlin
    Moffitt Cancer Center, University of South Florida College of Medicine, United States
  • Edward Bass
    Moffitt Cancer Center, University of South Florida College of Medicine, United States
  • Phuong Thuy Nguyen
    University of South Florida College of Medicine, United States
  • John Norman Greene
    Moffitt Cancer Center, University of South Florida College of Medicine, United States | john.greene@moffitt.org

Abstract

Tacrolimus is an immunosuppressive drug mainly used to lower the risk of transplant

rejection in individuals who are post solid organ or hematopoietic transplantation. It is a

macrolide which reduces peptidyl-propyl isomerase activity and inhibits calcineurin, thus

inhibiting T-lymphocyte signal transduction and interleukin-2 (IL-2) transcription. It has

been associated with Posterior Reversible Encephalopathy Syndrome (PRES), a disease

of sudden onset that can present as a host of different symptoms, depending on the

affected area of the brain. While infectious causes of encephalopathy must always be

entertained, the differential diagnosis should also include PRES in the appropriate

context. We report three cases of PRES in patients with acute myeloid leukemia (AML)

placed on tacrolimus after receiving a bone marrow transplant (BMT). The focus of this

review is to enhance clinical recognition of PRES as it is related to an adverse effect of

Tacrolimus in the setting of hematopoietic transplantation.

Keywords

PRES; Tacrolimus; Acute myeloid leukemia; Bone marrow transplant; Graft versus host disease

Full Text:

PDF
HTML
Submitted: 2014-07-21 14:10:41
Published: 2014-02-18 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
810

Views:
PDF
354
HTML
3099

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185